ALEXION PHARMACEUTICALS INC·4

May 22, 5:30 PM ET

ALEXION PHARMACEUTICALS INC 4

4 · ALEXION PHARMACEUTICALS INC · Filed May 22, 2015

Insider Transaction Report

Form 4
Period: 2015-05-20
Monnet Dominique
SVP, Chief Marketing Officer
Transactions
  • Sale

    Common Stock, par value $.0001 per share

    2015-05-20$162.40/sh256$41,5748,787 total
Footnotes (1)
  • [F1]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.

Documents

1 file
  • 4
    wf-form4_143233022256198.xmlPrimary

    FORM 4